NCT04791111View on ClinicalTrials.gov

AQUA: Anticholinergic Side Effects QUestionnAire

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

June 30, 2021

Study Completion Date

August 31, 2021

Conditions
Overactive Bladder
Interventions
OTHER

Questionnaire

validated questionnaire to assess side effects secondary to antimuscarinics treatment in neurogenic bladder

Trial Locations (1)

70020

department of Neuro-Urology, Hôpital Tenon, Paris

All Listed Sponsors
lead

Pierre and Marie Curie University

OTHER

NCT04791111 - AQUA: Anticholinergic Side Effects QUestionnAire | Biotech Hunter | Biotech Hunter